-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Annals of the Rheumatic Diseases, a top journal in the field of rheumatism, published a research article that aims to investigate the relationship between complete COVID-19 vaccination (two doses) and possible arthritis attacks
COVID-19
Researchers identified rheumatoid arthritis (RA) patients from population-based electronic medical records and divided them into BNT162b2 (mRNA vaccine), CoronaVac (inactivated virus vaccine) and non-vaccinated groups
Based on the diagnostic records during the episode , the researchers defined a probable arthritis episode as inpatient and outpatient consultations related to RA or reactive arthritis
diagnosis
In 5493 RA patients (BNT162b2: 653; CoronaVac: 671; unvaccinated: 4169), the propensity score-weighted Poisson regression showed no significant association between arthritis onset and COVID-19 vaccination (BNT162b2: adjusted The post-incidence ratio was 0.
Thus, the current evidence does not support that vaccination with COVID-19 mRNA or inactivated virus vaccine is associated with possible arthritis attacks
Current evidence does not support that vaccination with COVID-19 mRNA or inactivated virus vaccine is associated with possible arthritis attacks
Original source:
Xue Li,et al.
Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
in this message